Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Metformin shows promise for treating skin conditions, but more research is needed.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

New insights into skin damage from UV exposure suggest potential treatments, including targeting specific RNAs and combining therapies for better outcomes.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Fibroblasts are crucial in scar formation and wound healing, with potential therapies aiming for scarless healing.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Sunscreen technology is improving with new ingredients and methods to better protect skin from sun damage.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.